title: Adhesion of renal carcinoma cells to endothelial cells depends on PKCmu.
abstract: BACKGROUND
  The formation of metastases includes the separation of tumor cells from the primary tumor, cell migration into subendothelial tissue and cell proliferation in secondary organ. In this process, cell adhesion of tumor cells to the endothelium is an essential requirement for formation of metastases. Protein kinase C (PKC) regulates adhesion and proliferation. To identify a relation between PKC isoforms and tumor progression in renal cell carcinoma (RCC), the influence of PKC isoforms on cell adhesion and proliferation, and possible influences of integrins were analyzed in RCC cells.
  
  
  METHODS
  The experiments were performed in the RCC cell lines CCF-RC1 and CCF-RC2 after pre-incubation (16 h) with the PKC inhibitors GF109203X (inhibits PKCalpha, betaI, betaII, gamma, delta and epsilon), GO6976 (inhibits PKCalpha, betaI and mu), RO31-8220 (inhibits PKCalpha, betaI, betaII, gamma and epsilon) and rottlerin (inhibits PKCdelta). Cell adhesion was assessed through adherence of RCC cells to an endothelial monolayer. Cell proliferation was analyzed by a BrdU incorporation assay. The expression of beta1 integrins was analyzed by flow cytometry.
  
  
  RESULTS
  In CCF-RC1 cells, cell adhesion was significantly reduced by GO6976 to 55% and by RO31-8220 to 45% of control. In CCF-RC2 cells, only GO6976 induced a significant reduction of cell adhesion to 50% of control levels. Proliferation of both cell lines was reduced by rottlerin to 39% and 45% of control, respectively. The beta1 integrin expression on the cell surface of CCF-RC1 and CCR-RC2 cells was decreased by RO31-8220 to 8% and 7% of control, respectively. beta2 and beta3 integrins were undetectable in both cell lines.
  
  
  CONCLUSIONS
  The combination of the PKC inhibitors leads to the assumption that PKCmu influences cell adhesion in CCF-RC1 and CCF-RC2 cells, whereas in CCF-RC1 cells PKCepsilon also seems to be involved in this process. The expression of beta1 integrins appears to be regulated in particular by PKCepsilon. Cell proliferation was inhibited by rottlerin, so that PKCdelta might be involved in cell proliferation in these cells.
authors.affiliation: Department of Urology, University Medical Center Mainz, Mainz, Germany. brenner@uni-mainz.de
authors.forename: Walburgis
authors.initials: W
authors.lastname: Brenner
authors.forename: Silke
authors.initials: S
authors.lastname: Beitz
authors.forename: Elke
authors.initials: E
authors.lastname: Schneider
authors.forename: Frank
authors.initials: F
authors.lastname: Benzing
authors.forename: Ronald E
authors.initials: RE
authors.lastname: Unger
authors.forename: Frederik C
authors.initials: FC
authors.lastname: Roos
authors.forename: Joachim W
authors.initials: JW
authors.lastname: Thüroff
authors.forename: Christian
authors.initials: C
authors.lastname: Hampel
mesh_terms: D002292:Carcinoma, Renal Cell / Q000201:enzymology* / Q000473:pathology*; D002448:Cell Adhesion / Q000502:physiology; D048708:Cell Growth Processes / Q000502:physiology; D045744:Cell Line, Tumor; D042783:Endothelial Cells / Q000166:cytology; D006801:Humans; D039641:Integrin beta Chains / Q000096:biosynthesis; D007680:Kidney Neoplasms / Q000201:enzymology* / Q000473:pathology*; D011493:Protein Kinase C / Q000037:antagonists & inhibitors / Q000502:physiology*; D047428:Protein Kinase Inhibitors / Q000494:pharmacology
chemical_list: D039641:Integrin beta Chains; D047428:Protein Kinase Inhibitors; C089212:protein kinase D; D011493:Protein Kinase C
references.citation: J Urol. 1996 Feb;155(2):743-8
references.pmid: 8558717
references.citation: Breast Cancer Res. 2009;11(1):R13
references.pmid: 19243594
references.citation: J Biol Chem. 1997 May 23;272(21):13816-22
references.pmid: 9153238
references.citation: Mol Cell Endocrinol. 2008 Jul 16;289(1-2):77-84
references.pmid: 18534741
references.citation: Eur J Biochem. 1992 Sep 15;208(3):547-57
references.pmid: 1396661
references.citation: Cell Regul. 1991 May;2(5):347-55
references.pmid: 1716464
references.citation: Cancer Lett. 1999 Aug 23;143(1):15-21
references.pmid: 10465332
references.citation: J Immunol. 2007 Mar 15;178(6):3903-11
references.pmid: 17339490
references.citation: EMBO J. 2004 Jul 7;23(13):2531-43
references.pmid: 15192707
references.citation: Int J Oncol. 2008 May;32(5):1125-31
references.pmid: 18425341
references.citation: J Biol Chem. 1999 Jul 23;274(30):20805-11
references.pmid: 10409620
references.citation: Int J Cancer. 1992 Dec 2;52(6):918-23
references.pmid: 1281143
references.citation: Cancer Res. 2009 Feb 1;69(3):1117-24
references.pmid: 19141652
references.citation: J Biol Chem. 1996 May 31;271(22):13008-12
references.pmid: 8662811
references.citation: Annu Rev Cell Dev Biol. 1995;11:549-99
references.pmid: 8689569
references.citation: Cancer Res. 2008 May 15;68(10):3844-53
references.pmid: 18483269
references.citation: J Exp Zool A Comp Exp Biol. 2003 Aug 1;298(2):119-27
references.pmid: 12884273
references.citation: Mol Biol Cell. 2001 Sep;12(9):2699-710
references.pmid: 11553709
references.citation: Proc Natl Acad Sci U S A. 1992 Nov 1;89(21):10159-63
references.pmid: 1438205
references.citation: Curr Opin Cell Biol. 1997 Oct;9(5):725-31
references.pmid: 9330877
references.citation: J Cell Sci. 1998 Mar;111 ( Pt 5):657-65
references.pmid: 9454739
references.citation: Int J Cancer. 2002 May 1;99(1):53-7
references.pmid: 11948491
references.citation: Proc Natl Acad Sci U S A. 1994 Aug 30;91(18):8572-6
references.pmid: 8078925
references.citation: J Cell Biochem. 2009 Mar 1;106(4):714-28
references.pmid: 19173301
references.citation: Anticancer Res. 2003 Sep-Oct;23(5A):4001-6
references.pmid: 14666709
references.citation: Genome Biol. 2003;4(5):111
references.pmid: 12734000
references.citation: J Cell Biochem. 2008 May 1;104(1):82-95
references.pmid: 17979146
references.citation: Clin Exp Metastasis. 2008;25(4):305-24
references.pmid: 17906932
references.citation: Biochem Biophys Res Commun. 1994 Feb 28;199(1):93-8
references.pmid: 8123051
references.citation: Cancer Res. 1989 Dec 15;49(24 Pt 1):7064-71
references.pmid: 2582448
references.citation: J Exp Med. 1992 Jul 1;176(1):245-53
references.pmid: 1377224
references.citation: FEBS Lett. 2006 Nov 13;580(26):6069-75
references.pmid: 17054948
references.citation: Immunology. 1995 Nov;86(3):408-15
references.pmid: 8550078
references.citation: Mol Cell Biol. 1998 Nov;18(11):6719-28
references.pmid: 9774685
references.citation: Oncogene. 1999 Aug 5;18(31):4440-9
references.pmid: 10442635
references.citation: Microvasc Res. 2002 Nov;64(3):384-97
references.pmid: 12453433
references.citation: Blood. 2002 Nov 15;100(10):3741-8
references.pmid: 12393602
references.citation: EMBO J. 2002 Jul 15;21(14):3608-19
references.pmid: 12110574
references.citation: J Biol Chem. 2005 Apr 8;280(14):13205-8
references.pmid: 15701647
references.citation: J Biol Chem. 2004 Apr 16;279(16):16883-93
references.pmid: 14963034
references.citation: J Immunol. 2001 May 1;166(9):5755-62
references.pmid: 11313419
references.citation: Curr Opin Cell Biol. 1996 Apr;8(2):168-73
references.pmid: 8791416
references.citation: Blood. 1997 Dec 1;90(11):4341-53
references.pmid: 9373245
references.citation: J Pharmacol Exp Ther. 2006 Dec;319(3):1070-80
references.pmid: 16959960
references.citation: Cell. 1991 Jan 25;64(2):327-36
references.pmid: 1703045
references.citation: J Biol Chem. 2002 Feb 22;277(8):6490-6
references.pmid: 11741879
references.citation: Cancer Res. 1997 Sep 1;57(17):3812-7
references.pmid: 9288792
references.citation: Cell Growth Differ. 1996 Sep;7(9):1187-98
references.pmid: 8877100
references.citation: Cell Adhes Commun. 1993 May;1(1):67-81
references.pmid: 8081871
references.citation: Int J Cancer. 1995 Mar 16;60(6):753-8
references.pmid: 7896440
references.citation: Int J Biochem Cell Biol. 2002 Jun;34(6):577-81
references.pmid: 11943587
references.citation: J Biol Chem. 1995 Jan 6;270(1):78-86
references.pmid: 7814423
references.citation: Int J Oncol. 2004 Oct;25(4):1157-63
references.pmid: 15375568
references.citation: Curr Med Chem. 1999 Sep;6(9):877-903
references.pmid: 10495357
references.citation: Cell Signal. 2009 Feb;21(2):253-63
references.pmid: 19038333
references.citation: Br J Cancer. 2000 Mar;82(5):1063-9
references.pmid: 10737390
references.citation: Curr Opin Hematol. 2003 Mar;10(2):150-8
references.pmid: 12579042
references.citation: Cancer Res. 2001 Mar 15;61(6):2445-52
references.pmid: 11289113
references.citation: Exp Cell Res. 1999 Apr 10;248(1):260-71
references.pmid: 10094832
references.citation: Cancer Metastasis Rev. 1994 Dec;13(3-4):411-31
references.pmid: 7712599